0.4100
-0.0068
(-1.63%)
At close: April 17 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.25M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| CULLEY BRIAN M Chief Executive Officer | -- | Direct | -- | Feb 11, 2025 |
| SAMUEL GEORGE A. III General Counsel | -- | Direct | -- | Feb 11, 2025 |
| SAMUEL GEORGE A. III General Counsel | Purchase at price 0.60 per share. | Direct | 9,000 | Nov 26, 2024 |
| HOWE JILL ANN Chief Financial Officer | Purchase at price 0.59 per share. | Direct | 8,850 | Nov 26, 2024 |
| MULROY MICHAEL H Director | Purchase at price 0.57 per share. | Direct | 22,640 | Nov 22, 2024 |
| CULLEY BRIAN M Chief Executive Officer | Purchase at price 0.60 per share. | Direct | 24,000 | Nov 21, 2024 |
| HOWE JILL ANN Chief Financial Officer | Purchase at price 0.89 per share. | Direct | 9,345 | Aug 16, 2024 |
| CULLEY BRIAN M Chief Executive Officer | Purchase at price 1.05 per share. | Direct | 10,500 | May 24, 2024 |
| CULLEY BRIAN M Chief Executive Officer | -- | Direct | -- | Feb 9, 2024 |
| SAMUEL GEORGE A. III General Counsel | -- | Direct | -- | Feb 9, 2024 |
| BAILEY DON MATTHEW Director | Purchase at price 1.04 per share. | Indirect | 100,001 | Feb 8, 2024 |
| BROADWOOD PARTNERS, L.P. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.04 per share. | Direct | 7,000,001 | Feb 6, 2024 |
| JAYASURIYA ANULA Director | Purchase at price 1.09 per share. | Direct | 10,900 | Dec 29, 2023 |
| CULLEY BRIAN M Chief Executive Officer | -- | Direct | -- | Feb 10, 2023 |
| HOGGE GARY S Officer | -- | Direct | -- | Feb 10, 2023 |
| SAMUEL GEORGE A. III General Counsel | -- | Direct | -- | Feb 10, 2023 |
| KINGSLEY ALFRED D Director | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 1, 2022 |
| CULLEY BRIAN M Chief Executive Officer | -- | Direct | -- | Jun 30, 2022 |
| CULLEY BRIAN M Chief Executive Officer | Purchase at price 1.53 per share. | Direct | 9,792 | Mar 31, 2022 |
| CULLEY BRIAN M Chief Executive Officer | -- | Direct | -- | Mar 31, 2022 |
| AMIN DIPTI Director | Purchase at price 1.63 per share. | Direct | 57,050 | Mar 28, 2022 |
| BROADWOOD PARTNERS, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.37 - 1.44 per share. | Indirect | 1,317,667 | Mar 25, 2022 |
| CULLEY BRIAN M Chief Executive Officer | Purchase at price 1.38 per share. | Direct | 7,245 | Mar 25, 2022 |
| MULROY MICHAEL H Director | Purchase at price 1.40 per share. | Direct | 9,800 | Mar 24, 2022 |
| CULLEY BRIAN M Chief Executive Officer | -- | Direct | -- | Dec 31, 2021 |
| HOGGE GARY S Officer | Sale at price 2.44 - 2.49 per share. | Direct | 1,321,329 | Dec 29, 2021 |
| HOGGE GARY S Officer | Conversion of Exercise of derivative security at price 0.69 - 2.11 per share. | Direct | 725,104 | Dec 29, 2021 |
| KINGSLEY ALFRED D Director | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 1, 2021 |
| CULLEY BRIAN M Chief Executive Officer | -- | Direct | -- | Sep 30, 2021 |
| CULLEY BRIAN M Chief Executive Officer | Conversion of Exercise of derivative security at price 0.69 - 2.85 per share. | Direct | 251,602 | Jun 30, 2021 |
| RUSSELL ANGUS CHARLES Director | Sale at price 2.97 per share. | Direct | 14,018 | Jun 29, 2021 |
| RUSSELL ANGUS CHARLES Director | Conversion of Exercise of derivative security at price 2.20 per share. | Direct | 54,384 | Jun 29, 2021 |
| ANDREWS DEBORAH J Director | Sale at price 2.93 per share. | Direct | 56,086 | Jun 29, 2021 |
| ANDREWS DEBORAH J Director | Conversion of Exercise of derivative security at price 2.20 per share. | Direct | 54,384 | Jun 29, 2021 |
| CULLEY BRIAN M Chief Executive Officer | Sale at price 2.87 per share. | Direct | 1,291,500 | Jun 28, 2021 |
| BRADSHER NEAL C Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security at price 2.20 per share. | Direct | 54,384 | Jun 25, 2021 |
| KINGSLEY ALFRED D Director | Conversion of Exercise of derivative security at price 2.20 per share. | Direct | 135,960 | Jun 22, 2021 |
| MULROY MICHAEL H Director | Conversion of Exercise of derivative security at price 2.20 per share. | Direct | 54,384 | Jun 18, 2021 |
| CULLEY BRIAN M Chief Executive Officer | -- | Direct | -- | Mar 31, 2021 |
| HERNANDEZ ALEXANDRA Officer | Sale at price 2.23 per share. | Direct | 13,380 | Mar 30, 2021 |
| HERNANDEZ ALEXANDRA Officer | Conversion of Exercise of derivative security at price 0.69 per share. | Direct | 4,151 | Mar 30, 2021 |
| CULLEY BRIAN M Chief Executive Officer | -- | Direct | -- | Dec 31, 2020 |
| KINGSLEY ALFRED D Director | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 1, 2020 |
| CULLEY BRIAN M Chief Executive Officer | -- | Direct | -- | Sep 30, 2020 |
| CULLEY BRIAN M Chief Executive Officer | Conversion of Exercise of derivative security at price 0.87 per share. | Direct | 13,442 | Jun 30, 2020 |
| CULLEY BRIAN M Chief Executive Officer | Conversion of Exercise of derivative security at price 0.83 per share. | Direct | 12,794 | Mar 31, 2020 |
| CULLEY BRIAN M Chief Executive Officer | -- | Direct | -- | Dec 31, 2019 |
| CULLEY BRIAN M Chief Executive Officer | -- | Direct | -- | Sep 30, 2019 |
| CULLEY BRIAN M Chief Executive Officer | -- | Direct | -- | Sep 17, 2019 |
| KINGSLEY ALFRED D Director | Stock Gift at price 0.00 per share. | Direct | 0 | Aug 30, 2019 |
Related Tickers
GERN Geron Corporation
1.2700
+2.42%
SER Serina Therapeutics, Inc.
5.25
0.00%
MAIA MAIA Biotechnology, Inc.
1.5500
+0.65%
SLXN Silexion Therapeutics Corp
0.7500
-3.31%
BLRX BioLineRx Ltd.
2.8800
+3.97%
IVVD Invivyd, Inc.
0.5100
+8.21%
CGEN Compugen Ltd.
1.4700
+1.38%
IPSC Century Therapeutics, Inc.
0.5437
+8.74%
JSPR Jasper Therapeutics, Inc.
3.9700
+1.28%
FATE Fate Therapeutics, Inc.
1.1100
+5.71%